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ABSTRACT
Objectives: An investigation of the importance of hematological inflammatory markers on the prognosis of first trimester 
pregnancies and their role in predicting threatened abortion and early pregnancy loss.
Material and methods: This study was carried out in the Obstetrics and Gynecology Department of the Faculty of Medicine in 
our University between January 2018 and May 2019. Three-hundred individuals, 100 of them diagnosed with early pregnancy 
loss (EPL), 100 diagnosed with threatened abortion (TA) and 100 healthy control patients (HC), participated in the study. 
Results: There were no statistically significant differences in terms of hemoglobin, platelet, neutrophil count and NLR 
between the three groups. The RBC counts were significantly lower in EPL and TA compared to HC. Similarly, it was deter-
mined that the MPV value was significantly lower in EPL compared to HC. On the other hand, there was no difference in 
MPV between TA and HC. The PLR was higher in EPL and TA.
Conclusions: MPV, RBCs and PLR values were strongly associated with first-trimester miscarriage. These economical and 
easily measurable platelet indices can be used to predict fetal losses.
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INTRODUCTION
Early pregnancy loss is commonly seen, and its incidence 
has been reported to be in the range of 50 to 70% in all con-
ceptions [1]. The exact reason for early pregnancy loss has 
not been fully revealed. Although causal relationships and 
mechanisms cannot be fully explained, chromosomal anoma-
lies are held responsible for nearly half of the cases [2, 3], 
while the other half remain unknown. In recent years, data 
have indicated that a significant proportion of abortions have 
emerged as a result of problems with immunological mecha-
nisms and endocrinological factors that both mirror and are 
part of the immunological and haematological structure [4, 5].
Neutrophil-lymphocyte ratio (NLR) and platelet-lym-
phocyte (PLR) ratios are markers showing inflammatory sta-
tus. These rates could be easily determined with the blood test. 
These values chiefly indicate the presence of inflammatory 
load and are therefore utilized as prognostic indicators in 
many branches of medicine, and they have been frequently 
reported on and tested [6]. When the literature is examined, 
NLR and PLR have been examined in previous studies for 
pathological conditions such as gynecological cancers [7], 
ovarian hyperstimulation syndrome [8], early ovarian failure 
[9], endometriosis [10], hyperemesis gravidarum [11], gesta-
tional diabetes [12], preeclampsia [13], pregnancy-associated 
intrahepatic cholestasis [14] and other diseases. The increased 
values of these parameters must be taken into serious consid-
eration, especially during pregnancy. Numerous physiological 
changes occur during pregnancy, and these changes lead to 
special reference values for the evaluation of laboratory assays.
This research aimed to determine pregnancy-related refer-
ence values for NLR and PLR in accordance with the first trimes-
ter and investigated the importance of hematological inflam-
matory markers on the prognosis of first trimester pregnancies.
MATERIAL AND METHODS
Study design and patient population
The present study adopted a retrospective, one-centre, 
case-control approach and was carried out in the Obstetrics 
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and Gynecology Department of our University. The research 
was carried out in compliance with the approved guidelines 
and the principles expressed by the Helsinki Declaration 
[Ethics Committee Date and Number: (09.04.2019-03/09)].
A total of 300 patients were included this study. One 
hundred of them were the threatened abortion group (TAG), 
one hundred of them were the early pregnancy loss group 
(EPLG) and 100 of them were the healthy control group 
(HCG). The patient data were collected from hospital re-
cords over the last 2 years. Demographic parameters were 
recorded from patient files and laboratory parameters were 
recorded from complete blood cell count (CBC) results at 
the first trimester.
The first-trimester (7–14 weeks) CBC values were deter-
mined for all patients. Patients in any condition that could 
affect blood parameters such as multiple pregnancy, fetal 
infections, and amniocentesis were excluded from the study.
In the case of the presence of multiple CBC results, the 
result during 7 weeks of pregnancy was taken into consid-
eration and used in the statistical evaluation. NLR was calcu-
lated by dividing the number of neutrophils by the number 
of lymphocytes, and PLT by dividing the number of platelets 
by the number of lymphocytes. NLR, PLR, mean platelet vol-
ume (MPV), neutrophil counts, platelet counts, lymphocyte 
counts, red blood cell (RBC) counts and hemoglobin levels 
were determined for the three study groups. In all cases, 
blood samples were collected in tripotassium Ethylenedi-
aminetetraacetic acid (EDTA) tubes. All measurements of 
hematologic parameters were performed using a Beck-
man Coulter blood count analyzer (Beckman Coulter Inc., 
CA, USA) 30 minutes after blood collection.
Statistical Analyses
The statistics software package SPSS 25 (IBM, Armonk, 
NY: IBM Corp.) was used for the statistical evaluations in 
the present study. Descriptive statistics (mean, standard 
deviation, median, minimum value, maximum value and 
percentage value) were determined for discrete and con-
tinuous variables. Also, Levene’s test was adopted for the 
determination of the homogeneity of the variance re-
sults. The normality of the data’s distribution was evaluated 
using the Shapiro–Wilk test. The differences between three 
or more groups is determined by a one-way ANOVA test 
when the parametric test prerequisites are fulfilled, and 
the Kruskal Wallis test is used when such prerequisites 
are not fulfilled. A multiple comparison test, the Bonfer-
roni correction method, is used to evaluate the significant 
results of three or more groups. The determined variable 
cut-off values for RBCs (106 uL), hemoglobin (g/dL), plate-
lets (103 uL), MPV (fL, mean ± SD), neutrophils (103 uL), lym-
phocytes (103 uL), NLR and PLR responses were evaluated 
by receiver operating characteristic (ROC) analysis. Also, 
the Area Under the Curve (AUC) value, sensitivity and speci-
ficity values were calculated. The level of significance was 
set as p < 0.05.
RESULTS
The results obtained in the present study revealed that 
the differences in age, gravidity, parity, height, body weight, 
BMI, smoking habits and alcohol intake values were statisti-
cally not significant between the pregnant women, the wom-
en with a history of early pregnancy loss (EPL) and threatened 
abortion  (TA), and the healthy group (p > 0.05 for each).
The differences in hemoglobin count, platelet count, 
neutrophil count and NLR values between the three 
groups were not statistically significant (p = 0.15, p = 0.45, 
p = 0.65 and p = 0.19, respectively) (Tab. 1). 
The RBC counts were significantly lower in EPLG and 
TAG compared to HCG (4.63 ± 0.32 vs 4.8 ± 0.35 106 uL 
and 4.52 ± 0.39 vs 4.8 ± 0.35 106 uL for p < 0.001, respec-
tively). Similarly, MPV was found to be significantly lower in 
EPLG compared to HCG (8.71 ± 0.93 fL vs 10.6 ± 0.85 fL for 
p < 0.001, respectively). On the other hand, there was no 
difference in MPV between TAG and HCG (10.01 ± 1.25 fL vs 
10.6 ± 0.85 fL for p > 0.05). The PLR was higher in EPLG and 
TAG (148.01 ± 38.24 vs 122.9 ± 29.65 and 134.26 ± 42.51 vs 
122.9 ± 29.65 for p < 0.001, respectively) (Tab. 1). 
Prognostic values of the optimum cut-offs for first-tri-
mester neutrophil counts, lymphocyte counts, platelet 
counts, mean platelet volume, neutrophil–lymphocytes 
ratio and platelet–lymphocyte ratio for predicting EPL and 
TA are summarized in Tables 2a and 2b.
A cut-off value of ≤ 9.6 in the ROC analysis — performed 
to investigate the effect of the MPV value in predicting EPL 
— produced a sensitivity of 88% and a specificity of 88%. 
The Area Under the Curve (AUC) for the MPV was 0.937 (95% CI: 
75.7 to 95.5 %, p < 0.001) (Fig. 1a).
The AUC for PLR was 0.686 (p < 0.001) in EPLG (Fig. 1b). 
The sensitivity and specificity of the PLR were determined 
to be 78% and 50%, respectively, at a threshold PLR value 
of > 115.41. Values > 115.41 were significantly related to 
an increased risk of EPL. 
The AUC for RBCs was found to be 0.633 (p < 0.017) in 
EPLG (Fig. 1c). The sensitivity and specificity of the RBCs were 
determined to be 46% and 76%, respectively, at a threshold 
RBC value of ≤ 4.57 for EPL.
A cut-off value of ≤ 9.7 in the ROC analysis — performed 
to investigate the effect of the MPV value in predicting TA 
— produced a sensitivity of 40% and specificity of 84%. The 
AUC for the MPV was 0.631 (p < 0.019) (Fig. 2a).
The AUC for RBCs was found to be 0.698 (p < 0.01) (Fig. 2b). 
The sensitivity and specificity of the RBCs were found to 
be 54% and 84%, respectively, at a threshold RBC value 
of ≤ 4.45 in TA.
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DISCUSSION
Sacks et al. [15] reported that there was a large proinflam-
matory macrophage and natural killer cell flow in human de-
cidua in the first trimester detected in the fourth week of preg-
nancy. In the present case-control study, the hypothesis was 
structured on the possible association of NLR and PLR — two 
of the systemic inflammatory markers in the first trimester of 
pregnancy — with successful pregnancy results in the first tri-
mester. Based on the literature research carried on this subject, 
this is the first case-control study to examine the efficacy of he-
matological inflammatory markers for diagnosing EPL and TA.
Early pregnancy is a hypoxic case that may quicken 
angiogenesis. Moreover, in a recent study, it has been re-
ported that severe hypoxia and abnormal vascular endothe-
lial growth factor signals may cause pregnancy loss [16]. All 
the markers studied are expensive and involve non-routine 
tests; in addition, the exact mechanism underlying the re-
lationship with EPL and TA are unknown.
Significant increases in some CBC parameters, such as 
WBC (white blood cell) type, change during pregnancy, 
and a decrease in the ratio of granulocytes and T helper 
(Th) -1 lymphocytes, as well as a decrease in the ratio of 
Th-2 lymphocytes and monocytes, are observed in normal 
pregnancy conditions [17]. Macrophages and monocytes 
are of importance in the development of the placenta. Mac-
rophages and monocytes promote the invasion of extravil-
lous trophoblasts, spiral artery remodeling and the parturition 
process. On the other hand, there are controversial reports in 
published literature regarding the association of the deregu-
lation of these cells with complications during pregnancy, 
such as abortion, preeclampsia and preterm labour [18].
MPV, which shows platelet activation and function, is meas-
ured as a maximum amplitude (EPL). MPV is a precise measure 
of the platelet size. Larger platelets have higher MPV values; 
therefore, higher MPV is more reactive and causes higher values 
of hemostatic prothrombotic factors [19]. Moreover, in a group 
of patients with maternal thrombophilia, hypercoagulability 
may lead to low perfusion of the placenta, and ultimately, this 
may cause loss of the fetus [19]. Kosus et al. found slightly in-
creased EPL values for patient MPV. The researchers concluded 
that slightly increased MPV might encourage thrombosis [20]. 
On the other hand, some investigators suggested that MPV was 
significantly lower in patients with miscarriage compared to 
the control group [21]. In this study, MPV values were found 
to be significantly lower in EPLG than in TAG and HCG. It was 
concluded that due to inflammation and bleeding, platelets 
with higher activity (larger platelets) can migrate to the region 
in earlier gestational weeks, and this may lead to a decrease in 
MPV in maternal circulation in EPLG.
NLR is a marker that is important in inflammatory con-
ditions. leukocyte types may vary depending on immune 
response. Neutrophil count values increase whereas lym-
phocyte counts decrease. NLR varies in various systemic 
inflammatory diseases. Various researchers have reported 
that there was an increase in the prognostic and predictive 
values of NLR in cases including colorectal and lung cancers, 
and in hepatocellular carcinoma [7]. In addition, significant 
changes were observed in NLR values for various conditions 
seen during pregnancy. Kurtoglu et al. [22] reported high 
NLR values in preeclampsia. Similarly, significant changes 
were observed in NLR values in gestational diabetes, intra-
hepatic cholestasis and hyperemesis gravidarum [11, 12, 14]. 
In the present study, the relationship between NLR, EPL and 
TA were not found to be significant.
PLR is another marker used to analyze thromboem-
bolic events, inflammatory diseases and malignancies. It 
Table 1. Can neutrophils count lymphocytes count platelet count mean platelet volüme neutrophils-lymphocytes ratio and platelets-lymphocytes 
ratio during the first trimester of pregnancy predict early pregnancy loss and threatened abortion?
Demographic and clinical characteristics of patients Early pregnancy loss Threatened abortion Healty control p
Age [years] 27.7 ± 4.7 28.1 ± 4.0 27.1 ± 5.2 0.56
Gravida [number] 2.2 ± 2.7 2.8 ± 1.8 2.6 ± 1.8 0.11
Parity [number] 2.0 ± 1.1 1.9 ± 1.1 2.2 ± 3.7 0.84
Gestational age [week] 10 ± 2.1 11 ± 0.9 10 ± 1.8 0.91
RBCs [106 uL] 4.63 ± 0.32a 4.52 ± 0.39a 4.8 ± 0.35b 0.001**
Hemoglobin [g/dL] 12.63 ± 1.57 12.86 ± 1.13 13.15 ± 1.17 0.15
Platelets [103 uL] 271.62 ± 68.65 259.22 ± 45.89 272.64 ± 60.77 0.45
MPV [fL. mean ± SD] 8.71 ± 0.93a 10.01 ± 1.25b 10.6 ± 0.85b 0.001**
Neutrophils [103 uL] 5.81 ± 2.18 6.16 ± 2.12 6.11 ± 1.74 0.65
Lymphocytes [103 uL] 1.91 ± 0.57a 2.06 ± 0.51b 2.29 ± 0.57c 0.001**
NLR 3.19 ± 1.32 3.22 ± 1.75 2.77 ± 0.94 0.19
PLR 148.01 ± 38.24a 134.26 ± 42.51b 122.9 ± 29.65c 0.001**
RBCs — red blood cells; NLR — neutrophils-lymphocytes ratio; PLR — platelets-lymphocytes ratio; MPV — mean platelet volüme; **p < 0.01
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has been reported that there is a significant relationship 
between the increase in PLR and major side effects in car-
diovascular diseases and the decrease in the survival rate 
in some malignancies [23, 24]. PLR has been previously 
examined in pregnancy-related issues such as gestational 
diabetes, preeclampsia, pancreatitis and early premature 
rupture of membranes (PPROM) [12, 13, 25]. Endothelial 
dysfunction and the increase in elevated PLR can be as-
sociated with an increase in hemostatic functions which 
lead to the thrombosis of spiral arterioles. In another study, 
it has been stated that platelet activation is of utmost im-
portance in the etiopathogenesis of arterial occlusion and 
could also lead to injury to the endothelium, consequently, 
leading to an increase in thromboxane A2 values [26]. Tola 
EN. found a negative relationship between PLR and embry-
onic implantation. They explained this through thrombosis 
of spiral arterioles [27]. Our study is the first to show that 
PLR is an important predictor of EPL and TA. In the current 
study, PLR was higher in EPLG and TAG (148.01 ± 38.24 vs 
122.9 ± 29.65, 134.26 ± 42.51 vs 122.9 ± 29.65 for p < 0.001, 
respectively) (Tab. 1). 
A small sample size and lack of a power calculation 
constitute the inherent limitations of the present study. 
In addition, the fact that the research uses a retrospective 
design and its use of data from a single tertiary medical 
centre limits extrapolation of the results to the general 
population. In spite of these limitations, this study is the first 
that investigates the relationship between CBC inflamma-
tion markers, and EPL and TA.
CONCLUSIONS
MPV, RBCs and PLR values were associated with first-tri-
mester miscarriage. These platelet indices, which are not 
expensive and are easy-to-apply, can be used to predict 
fetal losses. Future studies on this subject should focus on 
randomized, prospective, controlled trials carried out on 
a larger subject group to obtain more precise conclusions.
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